Operating profit margin has declined from 33.51% to 28.47%, leading to 10.93% decline in operating profit to Rs 301.32 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 32.79% to 32.33%.   Purchase of finished goods cost rose from 0.80% to 1.31%.   Employee cost decreased from 6.13% to 5.29%.   Other expenses rose from 26.56% to 32.67%.   Selling and administration expenses rose from 8.99% to 11.63%.   

Other income fell 39.33% to Rs 5.8 crore.  PBIDT fell 11.71% to Rs 307.12 crore.  Provision for interest up 63.89% to Rs 0.59 crore.  

PBDT fell 11.79% to Rs 306.53 crore.  Provision for depreciation rose 7.54% to Rs 12.69 crore.  

Profit before tax down 12.47% to Rs 293.84 crore.  Provision for tax was expense of Rs 75.55 crore, compared to Rs 81.84 crore.  Effective tax rate was 25.71% compared to 24.38%.

Profit after tax fell 14.01% to Rs 218.29 crore.  

Promoters' stake was 70.64% as of 30 September 2021 ,compared to 70.64% as of 30 September 2020 .  

Full year results analysis

Net sales (including other operating income) of Procter & Gamble Hygiene and Health Care has increased 19.06% to Rs 3,574.14 crore.  

Operating profit margin has jumped from 20.11% to 24.74%, leading to 46.47% rise in operating profit to Rs 884.28 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 35.29% to 31.48%.   Purchase of finished goods cost fell from 1.74% to 1.15%.   Employee cost decreased from 5.76% to 5.63%.   Other expenses fell from 37.15% to 37.07%.   Selling and administration expenses rose from 10.91% to 14.58%.   Provisions writeoffs cost fell from 0.46% to 0.21%.   Other provisions fell from 0.46% to 0.21%.   

Other income fell 10.72% to Rs 39.38 crore.  PBIDT rose 42.58% to Rs 923.66 crore.  Provision for interest up 0.66% to Rs 6.11 crore.  Loan funds remained nil.  Inventories rose to Rs 249.30 crore as of 30 June 2021 from Rs 205.05 crore as of 30 June 2020.  Sundry debtors were lower at Rs 142.35 crore as of 30 June 2021 compared to Rs 166.34 crore as of 30 June 2020.  Cash and bank balance declined from Rs 902.50 crore as of 30 June 2020 to Rs 660.24 crore as of 30 June 2021.  

PBDT rose 42.98% to Rs 917.55 crore.  Provision for depreciation down 0.46% to Rs 47.66 crore.  Fixed assets declined from Rs 228.65 crore as of 30 June 2020 to Rs 221.39 crore as of 30 June 2021.  

Profit before tax grew 46.48% to Rs 869.89 crore.  Provision for tax was expense of Rs 218.1 crore, compared to Rs 160.79 crore.  Effective tax rate was 25.07% compared to 27.07%.

Profit after tax rose 50.50% to Rs 651.79 crore.  

Promoters' stake was 70.64% as of 30 June 2021 ,compared to 70.64% as of 30 June 2020 .  

Cash flow from operating activities increased to Rs 863.12 crore for year ended June 2021 from Rs 473.75 crore for year ended June 2020.  Cash flow used in acquiring fixed assets during the year ended June 2021 stood at Rs 31.60 crore, compared to Rs 51.02 crore during the year ended June 2020.

Management commentary: Madhusudan Gopalan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, "Despite a challenging market environment and a higher base period, we delivered strong growth in the first quarter driven by the strength of our trusted product portfolio and strong retail execution. We continue to remain focused on our strategy of driving superiority, improving productivity, leading constructive disruption, and strengthening our organization and culture. As the industry faces commodity inflation, we have doubled down our focus on driving productivity and innovation to drive balanced top and bottom line growth."